user avatar
CSIR-CCMB
@ccmb_csir
CSIR-Centre For Cellular And Molecular Biology, a national life science research institute in India, curated by @SomdattaKarak
Hyderabad, India
ccmb.res.in
Joined May 2016
449
Following
30K
Followers
Posts
  • Pinned
    user avatar
    CSIR-CCMB
    @ccmb_csir
    Jun 3
    The only way to endure the summer is to grab an ice popsicle and indulge in the cool and important findings that have come out of CCMB in the last month. The Daak will take you through lives of wildlife around us to the workings of living cells: mailchi.mp/d4b035959fa7/c… @CSIR_IND
    404
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    May 5, 2021
    #COVID19India #COVID19 #coronavirus In light of the many reports on coronavirus variant N440K lately, we would like to bring to your attention a few things: 1. The mutant is not new. We have been seeing it in South India since last year. @CSIR_IND @AndhraPradeshCM (1/3) More👇🏾
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    Oct 3, 2023
    Many congratulations to Manjula Reddy for her JC Bose Fellowship. More power to her work on bacterial growth. @CSIR_IND
    28K
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    Jan 12, 2025
    The Genome India Project offers us 10,000 genomes that represent the 4 broad linguistic groups, and regions across India incl tribal populations. They are available at the Indian Biological Data Centre at RCB, Faridabad for academics to analyze and unveil mysteries held in them.
    33K
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    May 8, 2021
    From testing of DRDO and Dr Reddy Lab's 2-DG (2-deoxy-D-glucose) on coronavirus in cell culture at CCMB to successfully clearing the phase 3 trials, it will now be used on moderate to severe COVID-19 patients. DCGI approval has come.
    Responding to Prime Minister Narendra Modi’s call for preparedness against the pandemic, the DRDO took the initiative of developing anti-Covid therapeutic application of 2-DG
    DCGI gives emergency approval of DRDO-developed anti-Covid oral drug
    From hindustantimes.com
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    Mar 21, 2020
    Training on for doctors and academics from microbiology depts of hospitals of Warangal and #Hyderabad. They will be trained on RNA isolation and one-step RT PCR to test for #COVID19 with reagents suggested by @ICMRDELHI. More trainings with more folks to happen the next few days.
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    Oct 12, 2022
    Many congratulations to Avni Blotra for securing the Royal Society for Tropical Medicine and Hygiene Early Career Grants Award 2022. She will look into toxicity of venom components that stay after partial neutralisation by the Indian polyvalent antivenom against snakebites.
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    Jun 1, 2020
    Here is a fresh preprint on genome analysis of SARS-CoV2 spread in India. The results show that a distinct cluster of virus population, uncharacterized thus far, which is prevalent in India - called the Clade A3i. (1/2) biorxiv.org/content/10.110…
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    May 5, 2021
    Replying to @ccmb_csir
    3. Our main focus as a community should be on reducing the spread of coronavirus. The more it spreads, the more variants come up, the more mess we create by increasing uncertainties and fear. So, see 👇🏾
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    Jan 2, 2023
    Many congratulations to @Ishwariya13 for starting her career as a Senior Scientist at CCMB. Welcome her and her fresh new research group! @CSIR_IND
    21K
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    May 5, 2021
    Replying to @ccmb_csir
    2. Though in controlled cell culture this variant makes more copies, it does not necessarily mean that it can compete with other variants just the same way in a real life pandemic where new variants keep coming up. Our genome studies say that N440K is now diminishing (2/3) More👇🏾
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    Jun 7, 2020
    As the lockdown is lifting, and workplaces are starting to get active, remember these basics. @CSIR_IND @CSIR_NISCAIR #CSIRfightsCOVID19
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    May 24, 2021
    Here is our next story in #IAmAScientist series. This time, we hear it from Manjula Reddy on how her career grew from loving chemistry to now mapping bacterial cell wall growth, and opening up new avenues in fighting #AntibioticResistance. ccmb.res.in/docs/zines/Map… #WomenInSTEM
  • user avatar
    CSIR-CCMB
    @ccmb_csir
    Apr 28, 2021
    We license the dry swab direct RT-PCR COVID19 testing method to Capital Health Services India Pvt Ltd for commercialization. Way to go for ramping up COVID19 testing across the country. @AIC_CCMB @CSIR_IND